|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/454 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3148545 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15800211.3 |
| Date of filing the European patent application | 2015-05-28 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/032869 |
| Date | 2015-05-28 |
| (87) | Number | WO 2015/184087 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 201462004061 P | 2014-05-28 | US |
| (72) |
BERENSON, James R. , US
|
| (73) |
Onco Tracker, Inc. ,
9201 Sunset Boulevard, Suite 300, West Hollywood, CA 90069,
US
|
| (54) | ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS |
| ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS |